Patents by Inventor Mathieu VASSELLE

Mathieu VASSELLE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Formulation
    Patent number: 11590243
    Abstract: The present invention relates to the formulation of adenoviral vectors in sorbitol containing compositions in combination with a further amorphous sugar, its formulation as well as a method for obtaining a dried composition.
    Type: Grant
    Filed: January 25, 2018
    Date of Patent: February 28, 2023
    Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Erwan Bourles, Olivier Despas, Delphine Guillaume, Frederic Mathot, Mathieu Vasselle
  • FORMULATIONS FOR SIMIAN ADENOVIRAL VECTORS HAVING ENHANCED STABILITY
    Publication number: 20210207171
    Abstract: The invention relates to liquid formulations of simian adenoviruses and methods for obtaining the formulations. The formulations comprise an amorphous sugar, Vitamin E succinate and recombinant human serum albumin in a buffered solution.
    Type: Application
    Filed: June 25, 2019
    Publication date: July 8, 2021
    Applicant: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Frédéric Stéphane MATHOT, Mathieu VASSELLE
  • NOVEL FORMULATION
    Publication number: 20190365930
    Abstract: The present invention relates to the formulation of adenoviral vectors in sorbitol containing compositions in combination with a further amorphous sugar, its formulation as well as a method for obtaining a dried composition.
    Type: Application
    Filed: January 25, 2018
    Publication date: December 5, 2019
    Applicant: GLAXOSMITHKLINE BIOLOGICALS S.A.
    Inventors: Erwan BOURLES, Olivier DESPAS, Delphine GUILLAUME, Frederic MATHOT, Mathieu VASSELLE